Growth Metrics

Incyte (INCY) Interest Coverage Ratio Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 79.36%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 29.25%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -16.86%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -1.78%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 40.09%
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 115.59%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 115.59%
Dec 31, 2025 76.43%
Sep 30, 2025 51.40%
Jun 30, 2025 33.50%
Mar 31, 2025 21.96%
Dec 31, 2024 69.70%
Sep 30, 2024 -29.40%
Jun 30, 2024 -56.73%
Mar 31, 2024 -8.08%
Dec 31, 2023 -15.33%
Sep 30, 2023 227.73%
Jun 30, 2023 -8.38%
Mar 31, 2023 26.99%
Dec 31, 2022 -12.44%
Sep 30, 2022 -1.37%
Jun 30, 2022 6.34%
Mar 31, 2022 -8.14%
Dec 31, 2021 62.24%
Sep 30, 2021 91.10%
Jun 30, 2021 23.44%
Mar 31, 2021 52.96%
Dec 31, 2020 341.16%
Sep 30, 2020 -48.96%
Jun 30, 2020 173.00%
Mar 31, 2020 -266.33%
Dec 31, 2019 191.19%
Sep 30, 2019 357.36%
Jun 30, 2019 307.41%
Mar 31, 2019 296.16%
Dec 31, 2018 -244.26%
Sep 30, 2018 1,943.18%
Jun 30, 2018 589.02%
Mar 31, 2018 -583.20%
Dec 31, 2017 61.12%
Sep 30, 2017 129.36%
Jun 30, 2017 117.11%
Mar 31, 2017 -123.70%
Dec 31, 2016 -28.51%
Sep 30, 2016 49.98%
Jun 30, 2016 39.98%
Mar 31, 2016 130.08%
Dec 31, 2015 12.93%
Sep 30, 2015 78.25%
Jun 30, 2015 -35.41%
Mar 31, 2015 43.48%
Dec 31, 2014 19.72%
Sep 30, 2014 53.22%
Jun 30, 2014 15.28%
Mar 31, 2014 -10.87%
Dec 31, 2013 -59.01%
Sep 30, 2013 6.54%
Jun 30, 2013 8.67%
Mar 31, 2013 40.80%